Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis

J Zhang, C Li, J Xu, Z Hu, SE Rutstein, JD Tucker… - The lancet HIV, 2022 - thelancet.com
Background Poor adherence to oral HIV pre-exposure prophylaxis (PrEP) diminishes its
clinical and public health benefits. This study synthesises evidence regarding …

Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review

KH Mayer, A Agwu, D Malebranche - Advances in therapy, 2020 - Springer
Antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV transmission was first
approved by the US Food and Drug Administration in 2012. Despite correlations of …

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a …

KH Mayer, JM Molina, MA Thompson, PL Anderson… - The Lancet, 2020 - thelancet.com
Background Tenofovir alafenamide shows high antiviral efficacy and improved renal and
bone safety compared with tenofovir disoproxil fumarate when used for HIV treatment. Here …

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel

MS Saag, CA Benson, RT Gandhi, JF Hoy… - Jama, 2018 - jamanetwork.com
Importance Antiretroviral therapy (ART) is the cornerstone of prevention and management of
HIV infection. Objective To evaluate new data and treatments and incorporate this …

Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection

MW Traeger, VJ Cornelisse, J Asselin, B Price, NJ Roth… - Jama, 2019 - jamanetwork.com
Importance Emerging evidence suggests that risk of bacterial sexually transmitted infections
(STIs) increases among gay and bisexual men following initiation of HIV preexposure …

Sexually transmitted infections: challenges ahead

M Unemo, CS Bradshaw, JS Hocking… - The Lancet infectious …, 2017 - thelancet.com
WHO estimated that nearly 1 million people become infected every day with any of four
curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and …

Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study

BR Bavinton, AN Pinto, N Phanuphak, B Grinsztejn… - The lancet HIV, 2018 - thelancet.com
Background Evidence on viral load and HIV transmission risk in HIV-serodiscordant male
homosexual couples is limited to one published study. We calculated transmission rates in …

On-demand preexposure prophylaxis in men at high risk for HIV-1 infection

JM Molina, C Capitant, B Spire, G Pialoux… - … England Journal of …, 2015 - Mass Medical Soc
Background Antiretroviral preexposure prophylaxis has been shown to reduce the risk of
human immunodeficiency virus type 1 (HIV-1) infection in some studies, but conflicting …

[HTML][HTML] Artificial intelligence and the implementation challenge

J Shaw, F Rudzicz, T Jamieson, A Goldfarb - Journal of medical Internet …, 2019 - jmir.org
Background Applications of artificial intelligence (AI) in health care have garnered much
attention in recent years, but the implementation issues posed by AI have not been …

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

JM Molina, I Charreau, B Spire, L Cotte, J Chas… - The lancet HIV, 2017 - thelancet.com
Background Data for on-demand pre-exposure prophylaxis (PrEP) are scarce. We
implemented a cohort study to assess its efficacy, safety, and effect on sexual behaviour …